INITIATOR PHARMA

initiator-pharma-logo

Initiator Pharma is a Biotech company established in Aarhus, Denmark. Its main asset IPED2015 represents a novel treatment paradigm for the treatment of Erectile Dysfunction (ED) and will improve the quality of life for the growing number for patients (and their partners) that do not respond or cannot be treated with the current marketed medication.

#People #Website #More

INITIATOR PHARMA

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2016-01-01

Address:
Copenhagen, Hovedstaden, Denmark

Country:
Denmark

Website Url:
http://www.initiatorpharma.com

Total Employee:
1+

Status:
Active

Contact:
+45 6126 0035

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache


Current Employees Featured

ulf-simonsen_image

Ulf Simonsen
Ulf Simonsen Chief Scientific Officer & Co-Founder @ Initiator Pharma
Chief Scientific Officer & Co-Founder
2016-01-01

claus-elsborg-olesen_image

Claus Elsborg Olesen
Claus Elsborg Olesen Co-Founder & CEO @ Initiator Pharma
Co-Founder & CEO
2016-05-01

not_available_image

Dan Peters
Dan Peters Co-founder @ Initiator Pharma
Co-founder
2016-01-01

Founder


claus-elsborg-olesen_image

Claus Elsborg Olesen

not_available_image

Dan Peters

ulf-simonsen_image

Ulf Simonsen

Official Site Inspections

http://www.initiatorpharma.com

  • Host name: 104.18.1.98
  • IP address: 104.18.1.98
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Initiator Pharma"

Initiator Pharma

Mar 25, 2025 Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet medical needs within the central and peripheral nervous system.See details»

Initiator Pharma - Crunchbase Company Profile

Initiator Pharma is a Biotech company. Initiator Pharma is a Biotech company established in Aarhus, Denmark. Its main asset IPED2015 represents a novel โ€ฆSee details»

Initiator Pharma A/S โ€“ Initiator Pharma

May 3, 2023 For more information, please visit www.initiatorpharma.com. Attachments. Initiator Pharma A/S Appendix 1 Initiator Pharma AS Draft Articles Of Association AGM 2023 Final โ€ฆSee details»

Management โ€“ Initiator Pharma

Born: 1963 Background: Ulf (MD., PhD) is trained as a medical doctor from Aarhus University and earned his PhD in physiology from Complutense University, Madrid, Spain in 1994.He became Professor of Pharmacology at โ€ฆSee details»

Initiator Pharma A/S (INIT.ST) - Yahoo Finance

See the company profile for Initiator Pharma A/S (INIT.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Initiator Pharma A/S, Financial Info, Board and Management ...

Newsletter. (c) Pateleon AB 2020 All Rights ReservedSee details»

Initiator Pharma (STO:INIT) Company Profile & Description - Stock โ€ฆ

Company profile for Initiator Pharma A/S (STO:INIT) with a description, list of executives, contact details and other key facts.See details»

Initiator Pharma Overview | SignalHire Company Profile

Initiator Pharma is a public company that has been in the industry for 7 years. The company currently specializes in the Biotechnology area. Its headquarters is located at Aarhus, Central โ€ฆSee details»

Initiator Pharma - LinkedIn

Initiator Pharma A/S, a clinical-stage pharma company developing innovative drugs targeting key unmet medical needs within the central and peripheral nervous system.See details»

Initiator Pharma - Overview, News & Similar companies - ZoomInfo

Oct 19, 2021 Initiator Pharma contact info: Phone number: +45 61260035 Website: www.initiatorpharma.com What does Initiator Pharma do? Initiator Pharma is a clinical-stage โ€ฆSee details»

Initiator Pharma A/S | DANISH BIO โ€“ DANSK BIOTEK

Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet medical needs within the central and peripheral nervous system.See details»

Initiator Pharma - Products, Competitors, Financials, Employees ...

Initiatorpharma.com. Overview & Products; Financials; Founded Year 2016. Stage Corporate Minority - P2P | IPO. Market Cap 0.39B. Stock Price 7.20. About Initiator Pharma. Initiator โ€ฆSee details»

About Initiator Pharma

Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet medical needs within the central and peripheral nervous system.See details»

Initiator Pharma strengthens its management team and initiates its ...

Initiator Pharma recently signed a financing agreement with UK's largest independent clinical development organization, worth up to 23 MSEK, which secures the funding of the continued โ€ฆSee details»

Initiator Pharma 2025 Company Profile: Stock Performance

Initiator Pharma General Information Description. Initiator Pharma AS is a research and development company engaged in the pharmaceutical development of drugs to be used for โ€ฆSee details»

Initiator Pharma - Craft

Initiator Pharma has 1 employees across 2 locations. See insights on Initiator Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Investors โ€“ Initiator Pharma

Nov 29, 2024 Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet medical needs within the central and peripheral โ€ฆSee details»

Board of Directors โ€“ Initiator Pharma

Born: 1974 Background: Peter has a PhD in biochemistry from the Karolinska in Stockholm, and a Masterโ€™s degree in chemistry from the University of Linköping.Holm is a partner and European โ€ฆSee details»

Initiator Pharma - VentureRadar

Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet medical needs within the... ... Find out more ...See details»

INITIATOR PHARMA: Q1 2022 REPORT

Business highlights in Q1 2022 On January 20th the initiation of dosing in the IPTN2021 program Phase 1 to assess pain reducing effects in healthy...See details»